JPMORGAN CHASE & CO - CORBUS PHARMACEUTICALS HLDGS ownership

Back to all holdings Add to watchlist

CORBUS PHARMACEUTICALS HLDGS's ticker is and the CUSIP is 21833P953. A total of 3 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q3 2020$6,000
-91.4%
3,100
-76.9%
0.00%–
Q1 2020$70,000
-4.1%
13,4000.0%0.00%–
Q4 2019$73,000
+170.4%
13,400
+243.6%
0.00%–
Q1 2019$27,000
+17.4%
3,9000.0%0.00%–
Q4 2018$23,000–3,900–0.00%–
 Download
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q4 2020
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 18,500$23,0000.00%
SIMPLEX TRADING, LLC 278$34,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders